EM
CVS icon

Excalibur Management’s CVS Health CVS Stock Holding History

Excalibur Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.8M Sell
39,013
-236
-0.6% -$18.2K 1.01% 27
2025
Q4 		$3.11M Sell
39,249
-905
-2% -$71.3K 1.12% 21
2025
Q3 		$3.03M Sell
40,154
-672
-2% -$46.1K 1.1% 23
2025
Q2 		$2.82M Sell
40,826
-1,164
-3% -$76.3K 1.06% 23
2025
Q1 		$2.84M Buy
41,990
+130
+0.3% +$7.78K 1.12% 21
2024
Q4 		$1.88M Sell
41,860
-1,940
-4% -$109K 0.75% 33
2024
Q3 		$2.75M Sell
43,800
-1,984
-4% -$116K 1.05% 18
2024
Q2 		$2.7M Buy
45,784
+1,526
+3% +$95.5K 1.1% 18
2024
Q1 		$3.53M Buy
44,258
+178
+0.4% +$13.6K 1.49% 13
2023
Q4 		$3.48M Buy
44,080
+112
+0.3% +$7.97K 1.63% 11
2023
Q3 		$3.07M Buy
43,968
+630
+1% +$44.6K 1.6% 12
2023
Q2 		$3M Sell
43,338
-312
-0.7% -$22.2K 1.53% 12
2023
Q1 		$3.24M Sell
43,650
-485
-1% -$40.7K 1.68% 11
2022
Q4 		$4.11M Sell
44,135
-627
-1% -$60.5K 2.15% 10
2022
Q3 		$4.27M Sell
44,762
-819
-2% -$81.1K 2.39% 9
2022
Q2 		$4.22M Sell
45,581
-2,770
-6% -$270K 2.2% 9
2022
Q1 		$4.89M Sell
48,351
-2,169
-4% -$228K 2.12% 10
2021
Q4 		$5.21M Sell
50,520
-618
-1% -$57.1K 2.1% 11
2021
Q3 		$4.34M Sell
51,138
-2,467
-5% -$207K 1.9% 14
2021
Q2 		$4.47M Sell
53,605
-115
-0.2% -$9.42K 2.03% 13
2021
Q1 		$4.04M Sell
53,720
-1,080
-2% -$78.7K 1.99% 13
2020
Q4 		$3.74M Sell
54,800
-2,497
-4% -$162K 2.01% 13
2020
Q3 		$3.35M Sell
57,297
-1,210
-2% -$75.3K 2.03% 13
2020
Q2 		$3.8M Buy
58,507
+1,338
+2% +$84.3K 2.53% 12
2020
Q1 		$3.39M Buy
57,169
+3,208
+6% +$214K 2.62% 12
2019
Q4 		$4.01M Buy
53,961
+6,726
+14% +$472K 2.62% 12
2019
Q3 		$2.98M Buy
47,235
+903
+2% +$53.5K 2.67% 13
2019
Q2 		$2.52M Buy
46,332
+2,973
+7% +$160K 2.33% 13
2019
Q1 		$2.34M Buy
43,359
+1,767
+4% +$109K 2.2% 13
2018
Q4 		$2.73M Sell
41,592
-185
-0.4% -$13.8K 2.75% 12
2018
Q3 		$3.29M Sell
41,777
-6,515
-13% -$466K 2.81% 12
2018
Q2 		$3.11M Sell
48,292
-784
-2% -$51.7K 2.47% 13
2018
Q1 		$3.05M Buy
49,076
+35,050
+250% +$2.51M 2.48% 13
2017
Q4 		$1.02M Buy
14,026
+160
+1% +$11.6K 0.85% 32
2017
Q3 		$1.13M Buy
13,866
+175
+1% +$13.8K 0.96% 30
2017
Q2 		$1.1M Buy
13,691
+1,265
+10% +$99.9K 0.99% 27
2017
Q1 		$975K Buy
12,426
+703
+6% +$56.1K 0.87% 31
2016
Q4 		$925K Buy
11,723
+2,428
+26% +$196K 0.84% 30
2016
Q3 		$827K Buy
9,295
+3,290
+55% +$311K 0.78% 30
2016
Q2 		$575K Sell
6,005
-138
-2% -$13.8K 0.49% 36
2016
Q1 		$637K Buy
6,143
+300
+5% +$29.2K 0.57% 33
2015
Q4 		$571K Buy
5,843
+200
+4% +$19.6K 0.53% 32
2015
Q3 		$544K Sell
5,643
-1,000
-15% -$105K 0.54% 33
2015
Q2 		$697K Hold
6,643
– – 0.65% 32
2015
Q1 		$686K Sell
6,643
-85
-1% -$8.6K 0.66% 32
2014
Q4 		$648K Sell
6,728
-142
-2% -$12.5K 0.65% 30
2014
Q3 		$547K Hold
6,870
– – 0.56% 32
2014
Q2 		$518K Hold
6,870
– – 0.54% 33
2014
Q1 		$514K Sell
6,870
-1,850
-21% -$131K 0.56% 33
2013
Q4 		$624K Sell
8,720
-500
-5% -$32.1K 0.68% 30
2013
Q3 		$523K Hold
9,220
– – 0.61% 32
2013
Q2 		$527K Buy
+9,220
New +$534K 0.65% 32

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Excalibur Management's CVS Position: Q1 2026 in Review

Excalibur Management reduced its CVS Health (CVS) stake by 0.6% in Q1 2026, selling an estimated $18.2K and leaving 39,013 shares worth $2.8M. The position accounts for 1.01% of the portfolio, ranked #27.

Excalibur Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.21M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Excalibur Management held 39,013 shares of CVS Health worth $2.8M as of Q1 2026.
  • Excalibur Management sold 236 CVS Health shares in Q1 2026, an estimated $18.2K.
  • CVS Health made up 1.01% of Excalibur Management's portfolio in Q1 2026, its #27 holding.
  • Excalibur Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Excalibur Management's CVS Health position peaked at $5.21M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.